Aclaris Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC ACRS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

284,604

Value ($000)

857

Weight

0.0%

2019 Q4 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	857	0.0%	284,604	12/31/2025
2025 Q3	11/10/2025	460	0.0%	241,956	9/30/2025
2025 Q2	8/12/2025	371	0.0%	261,298	6/30/2025
2025 Q1	9/15/2025	51	0.0%	33,079	3/31/2025
2024 Q4	2/6/2025	82	0.0%	33,079	12/31/2024
2024 Q2	8/12/2024	287	0.0%	260,706	6/30/2024
2024 Q1	5/9/2024	520	0.0%	419,334	3/31/2024
2023 Q4	2/6/2024	458	0.0%	436,330	12/31/2023
2023 Q3	11/8/2023	3,173	0.0%	463,234	9/30/2023
2023 Q2	8/10/2023	4,607	0.0%	444,261	6/30/2023
2023 Q1	5/12/2023	3,319	0.0%	410,220	3/31/2023
2022 Q4	2/13/2023	6,491	0.0%	412,133	12/31/2022
2022 Q3	11/14/2022	6,337	0.0%	402,554	9/30/2022
2022 Q2	8/15/2022	2,155	0.0%	154,319	6/30/2022
2022 Q1	5/13/2022	2,295	0.0%	133,068	3/31/2022
2021 Q4	2/11/2022	1,875	0.0%	128,913	12/31/2021
2021 Q3	11/16/2021	2,285	0.0%	126,916	9/30/2021
2021 Q2	8/16/2021	1,894	0.0%	107,838	6/30/2021
2021 Q1	5/17/2021	398	0.0%	15,789	3/31/2021
2020 Q4	2/16/2021	133	0.0%	20,505	12/31/2020
2020 Q3	11/13/2020	53	0.0%	20,505	9/30/2020
2020 Q2	8/20/2020	34	0.0%	20,505	6/30/2020
2020 Q1	5/15/2020	89	0.0%	84,702	3/31/2020
2019 Q4	2/7/2020	161	0.0%	84,702	12/31/2019